Daniel Ontaneda

5.7k total citations
144 papers, 2.6k citations indexed

About

Daniel Ontaneda is a scholar working on Pathology and Forensic Medicine, Neurology and Rheumatology. According to data from OpenAlex, Daniel Ontaneda has authored 144 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 114 papers in Pathology and Forensic Medicine, 48 papers in Neurology and 26 papers in Rheumatology. Recurrent topics in Daniel Ontaneda's work include Multiple Sclerosis Research Studies (113 papers), Peripheral Neuropathies and Disorders (28 papers) and Rheumatoid Arthritis Research and Therapies (14 papers). Daniel Ontaneda is often cited by papers focused on Multiple Sclerosis Research Studies (113 papers), Peripheral Neuropathies and Disorders (28 papers) and Rheumatoid Arthritis Research and Therapies (14 papers). Daniel Ontaneda collaborates with scholars based in United States, United Kingdom and Canada. Daniel Ontaneda's co-authors include Robert J. Fox, Jeffrey A. Cohen, Kunio Nakamura, Jeremy Chataway, Alan J. Thompson, Gabrielle Macaron, Robert Bermel, Bruce D. Trapp, Moein Amin and Kedar Mahajan and has published in prestigious journals such as The Lancet, PLoS ONE and Neurology.

In The Last Decade

Daniel Ontaneda

137 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Ontaneda United States 30 1.9k 717 448 441 336 144 2.6k
Ángela Vidal‐Jordana Spain 22 1.7k 0.9× 630 0.9× 358 0.8× 473 1.1× 389 1.2× 76 2.3k
Dejan Jakimovski United States 29 2.1k 1.1× 764 1.1× 472 1.1× 511 1.2× 310 0.9× 179 3.0k
Paola Perini Italy 22 1.8k 1.0× 769 1.1× 314 0.7× 532 1.2× 257 0.8× 68 2.4k
Robert Bermel United States 30 1.9k 1.0× 617 0.9× 483 1.1× 519 1.2× 267 0.8× 84 2.7k
Bonnie I. Glanz United States 31 2.2k 1.2× 732 1.0× 704 1.6× 566 1.3× 287 0.9× 110 3.3k
Frank Dahlke Switzerland 23 1.9k 1.0× 790 1.1× 461 1.0× 535 1.2× 403 1.2× 77 2.5k
Marcelo Kremenchutzky Canada 23 2.3k 1.2× 944 1.3× 412 0.9× 735 1.7× 437 1.3× 64 2.9k
Celia Oreja‐Guevara Spain 28 1.8k 1.0× 726 1.0× 295 0.7× 342 0.8× 340 1.0× 137 2.6k
Deepa P. Ramasamy United States 34 2.1k 1.1× 938 1.3× 322 0.7× 562 1.3× 253 0.8× 107 3.0k
Šarlota Mesaroš Serbia 28 1.8k 0.9× 622 0.9× 303 0.7× 444 1.0× 158 0.5× 95 2.4k

Countries citing papers authored by Daniel Ontaneda

Since Specialization
Citations

This map shows the geographic impact of Daniel Ontaneda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Ontaneda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Ontaneda more than expected).

Fields of papers citing papers by Daniel Ontaneda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Ontaneda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Ontaneda. The network helps show where Daniel Ontaneda may publish in the future.

Co-authorship network of co-authors of Daniel Ontaneda

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Ontaneda. A scholar is included among the top collaborators of Daniel Ontaneda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Ontaneda. Daniel Ontaneda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mahajan, Kedar, et al.. (2025). Neurodegeneration and Demyelination in the Multiple Sclerosis Spinal Cord. Neurology. 104(7). e210259–e210259. 2 indexed citations
2.
Gaj, Sibaji, et al.. (2025). Subject‐Based Transfer Learning in Longitudinal Multiple Sclerosis Lesion Segmentation. Journal of Neuroimaging. 35(1). e70024–e70024. 1 indexed citations
3.
Kunchok, Amy, Moein Amin, Robert Bermel, et al.. (2025). Volumetric MRI Comparing Longitudinal Change in MOGAD to NMOSD , MS and Healthy Controls, and Disability Associations. Annals of Neurology. 98(5). 1044–1056.
4.
Li, Yadi, Alex Milinovich, Justin Abbatemarco, et al.. (2024). Longitudinal Disability, Cognitive Impairment, and Mood Symptoms in Patients With Anti-NMDA Receptor Encephalitis. Neurology. 102(4). e208019–e208019. 12 indexed citations
5.
McGinley, Marisa, et al.. (2024). Disparities in Utilization of Outpatient Telemedicine for Neurologic Care. Neurology Clinical Practice. 15(1). e200407–e200407. 1 indexed citations
6.
Hancock, Laura M., Rachel Galioto, Tasha Rhoads, et al.. (2024). Comparing Cognitive Profiles in Older Adults With Multiple Sclerosis and Alzheimer Disease. Neurology Clinical Practice. 14(4). e200327–e200327.
7.
Nadai, Alessandro S. De, et al.. (2024). Multiple sclerosis subgroups: Data-driven clusters based on patient-reported outcomes and a large clinical sample. Multiple Sclerosis Journal. 30(13). 1642–1652. 1 indexed citations
8.
Lace, John W., et al.. (2023). “It's on the tip of my tongue!” exploring confrontation naming difficulties in patients with multiple sclerosis. Multiple Sclerosis and Related Disorders. 71. 104579–104579. 5 indexed citations
9.
Abbatemarco, Justin, Daniel Ontaneda, Mary Rensel, et al.. (2023). Race and Social Determinants of Health in Performance Outcomes among Relapsing Remitting Multiple Sclerosis Patients (P13-3.017). Neurology. 100(17_supplement_2). 1 indexed citations
10.
Ontaneda, Daniel, Tanuja Chitnis, Kottil Rammohan, & Ahmed Z. Obeidat. (2023). Identification and management of subclinical disease activity in early multiple sclerosis: a review. Journal of Neurology. 271(4). 1497–1514. 18 indexed citations
11.
McGinley, Marisa, et al.. (2023). Geographic Disparities in Access to Neurologists and Multiple Sclerosis Care in the United States. Neurology. 102(2). e207916–e207916. 14 indexed citations
12.
Amin, Moein, et al.. (2023). Association Between Disease-Modifying Therapy and Information Processing Speed in Multiple Sclerosis. International Journal of MS Care. 26(3). 91–97. 3 indexed citations
13.
Garjani, Afagh, Christopher Allen, Douglas Gunzler, et al.. (2022). Decentralised clinical trials in multiple sclerosis research. Multiple Sclerosis Journal. 29(3). 317–325. 4 indexed citations
14.
Amin, Moein, Kunio Nakamura, & Daniel Ontaneda. (2022). Automated MRI features of MS and common radiological mimickers (P15-4.008). Neurology. 98(18_supplement). 1 indexed citations
15.
McGinley, Marisa, Daniel Ontaneda, Malory Weber, et al.. (2020). Teleneurology as a Solution for Outpatient Care During the COVID-19 Pandemic. Telemedicine Journal and e-Health. 26(12). 1537–1539. 37 indexed citations
16.
Dutta, Ranjan, Kedar Mahajan, Kunio Nakamura, et al.. (2019). Comprehensive Autopsy Program for Individuals with Multiple Sclerosis. Journal of Visualized Experiments. 15 indexed citations
17.
Nakamura, Kunio, A Deshmane, Yun Jiang, et al.. (2016). A Novel Method for Quantification of Normal Appearing Brain Tissue in Multiple Sclerosis: Magnetic Resonance Fingerprinting (P4.158). Neurology. 86(16_supplement). 5 indexed citations
18.
Bermel, Robert, et al.. (2014). Early Tolerability Of Dimethyl Fumarate For Treatment Of Multiple Sclerosis (P2.214). Neurology. 82(10_supplement). 1 indexed citations
19.
Ontaneda, Daniel & Robert J. Fox. (2013). Multiple Sclerosis Treatment. CONTINUUM Lifelong Learning in Neurology. 19(4). 1092–1099. 1 indexed citations
20.
Rae-Grant, Alex, et al.. (2010). Relapsing–Remitting Multiple Sclerosis—Current Treatment Options and Perspectives for the Future. 6(1). 64–64. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ángela Vidal‐Jordana Breakdown of academic impact, for papers by Dejan Jakimovski Breakdown of academic impact, for papers by Paola Perini Breakdown of academic impact, for papers by Robert Bermel Breakdown of academic impact, for papers by Bonnie I. Glanz Breakdown of academic impact, for papers by Frank Dahlke Breakdown of academic impact, for papers by Marcelo Kremenchutzky Breakdown of academic impact, for papers by Celia Oreja‐Guevara Breakdown of academic impact, for papers by Deepa P. Ramasamy Breakdown of academic impact, for papers by Šarlota Mesaroš
Rankless by CCL
2026